JELLY_1170x120_9-8-20

Figures and Trends

Analysis of HDA specialty distributors reveals continued growth

Analysis of HDA specialty distributors reveals continued growth

ARLINGTON, Va. — A new analysis published by the HDA Research Foundation indicates that oncology drugs, autoimmune and HIV therapeutics fueled specialty pharmaceutical segment growth in 2018. The 2019 Specialty Pharmaceutical Distribution: Facts, Figures and Trends indicates that oncology therapeutics account for most specialty distributor sales at 48.4%. “Specialty drugs account for nearly half of